Which Emerging Trends Are Driving The Prenatal Testing & Newborn Screening Market Toward $10.99 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Prenatal Testing & Newborn Screening Market Expected To Grow In Terms Of Size?
In recent times, the prenatal testing & newborn screening market has witnessed quick expansion. Currently valued at $6.24 billion in 2024, it is projected to escalate to $6.98 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. The previous period of growth can be credited mainly to the improvements in genetic testing, a rise in maternal age, amplified awareness and education, and evolving healthcare policies and regulations.
The market for prenatal testing & newborn screening is predicted to experience rapid expansion in the coming years. This market is set to reach a value of $10.99 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. The projected growth during the forecast period can be ascribed to factors such as genetic counseling, technological progress, point-of-care testing, telehealth, and remote monitoring. Other significant trends expected during this period entail non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, testing of maternal blood, as well as screening for hemoglobinopathies and sickle cell.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp
Which Key Factors Are Fueling Growth In The Prenatal Testing & Newborn Screening Market?
The high incidence of genetic disorders in babies has fueled the expansion of the prenatal testing & newborn screening market. Genetic diseases, as defined by the World Health Organization, comprise Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease among others. Sickle cell anemia, a genetic disease, impacts millions worldwide, especially those with ancestral roots in Africa, America, Cuba, Central America, Saudi Arabia, and India. For example, a study conducted at Rady Children’s Hospital by the Rady Children’s Institute for Genomic Medicine, a US research institute, in February 2023 revealed that 41% of infant deaths were due to single-locus (Mendelian) genetic diseases. Such high occurrence of genetic disorders in babies has amplified the demand and subsequently the growth of the prenatal testing and newborn screening market.
How Is The Prenatal Testing & Newborn Screening Market Categorized Across Applications And Types?
The prenatal testing & newborn screeningmarket covered in this report is segmented –
1) By Diagnostic Type: Non-Invasive; Invasive
2) By Technology: Screening Technology; Diagnostic Technology
3) By End user: Hospitals; Diagnostic centers
Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
How Are Industry Trends Steering The Expansion Of The Prenatal Testing & Newborn Screening Market?
Top players in the prenatal testing & newborn screening market are making strides towards implementing innovative programs that leverage rWGS (rapid Whole Genome Sequencing) technology. This cutting-edge technology enables swift and precise detection of genetic abnormalities in newborns, facilitating timely diagnosis and treatment and thereby improving health outcomes. Unlike traditional genetic tests that focus on specific genes or regions, rWGS technology sequences the complete genome of an individual, identifying genetic variations related to diseases or health conditions. For example, Rady Children’s Institute for Genomic Medicine, a US company, rolled out BeginNGS, a groundbreaking program in June 2022. This initiative aims to pinpoint and diagnose around 400 treatable genetic conditions before they start showing symptoms. BeginNGS is in the process of enhancing genomic sequencing procedures with the objective to widen its testing capabilities to manage nearly 1,000 disorders. The long-term goal is to standardize screening for 3.7 million newborns per year across hospitals nationwide.
Which Firms Are Making The Biggest Impact In The Prenatal Testing & Newborn Screening Market?
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Prenatal Testing & Newborn Screening Market Expansion?
North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp
Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2025, By The Business Research Company
Non Invasive Prenatal Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Testing Inspection And Certification Global Market Report 2025
Genetic Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
